Your session is about to expire
← Back to Search
CORI™ Knee Tensioner for Knee Replacement Surgery
N/A
Recruiting
Research Sponsored by Smith & Nephew, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Subject requires a cemented TKA as a primary indication due to any of the following conditions: Degenerative joint disease, including osteoarthritis, Rheumatoid arthritis, Avascular necrosis, Requires correction of functional deformity, Requires treatment of fractures that were unmanageable using other techniques
Subject is eighteen (18) years old or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-operative, 6 weeks, 6 months, and 12 months
Awards & highlights
Study Summary
This trial will help assess the performance of the REAL INTELLIGENCE™ Tensioner as an accessory to the CORI Surgical System for patients undergoing a robotic TKA procedure.
Who is the study for?
This trial is for adults over 18 who need a knee replacement due to conditions like osteoarthritis or rheumatoid arthritis and can follow up for one year. They must understand English, not be morbidly obese (BMI under 40), and have no active infections, severe joint diseases, or mental illness affecting compliance.Check my eligibility
What is being tested?
The CORI™ KNEE TENSIONER's performance is being tested as an accessory to the CORI™ Surgical System during knee replacement surgeries. The study aims to assess how well it works with the surgical system in improving surgery outcomes.See study design
What are the potential side effects?
While specific side effects are not listed for the tensioner itself, typical risks of knee surgery may include pain at the incision site, swelling, infection risk post-surgery, blood clots, stiffness in the knee joint, and possible damage to surrounding tissues.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I need a knee replacement due to arthritis, bone death, deformity, or unmanageable fractures.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre-operative, 6 weeks, 6 months, and 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-operative, 6 weeks, 6 months, and 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Quality of Life: EuroQol 5-Dimension 5-Level Visual Analogue Scale (EQ-5D-5L VAS) at 12 months
Secondary outcome measures
2011 Knee Society Score (KSS)
Quality of Life (EQ-5D-5L Index score)
Quality of Life: EuroQol 5-Dimension 5-Level Visual Analogue Scale (EQ-5D-5L VAS) pre-operative, 6 weeks, and 6 months
Other outcome measures
Medial-to-lateral balance measurements at 0/10°, 30°, 60°, and 90° flexion.
Trial Design
1Treatment groups
Experimental Treatment
Group I: CORI TENSIONERExperimental Treatment1 Intervention
Subjects having a robotic TKA procedure with the CORI Surgical System, including the use of the CORI™ KNEE TENSIONER accessory.
Find a Location
Who is running the clinical trial?
Smith & Nephew, Inc.Lead Sponsor
165 Previous Clinical Trials
22,391 Total Patients Enrolled
Kelli ArmstrongStudy ChairSmith & Nephew, Inc.
2 Previous Clinical Trials
284 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not pregnant, nursing, or if capable of becoming pregnant, I am using birth control.I do not have an active infection or sepsis.I need a complex knee replacement or revision due to a previous surgery failure.My BMI is over 40, classifying me as morbidly obese.I need a knee replacement due to arthritis, bone death, deformity, or unmanageable fractures.I do not have any health conditions that would make it unsafe for me to join the study.I have arthritis caused by a past injury.I need knee replacement surgery on both knees.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: CORI TENSIONER
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger